...Nearly 20 years since the launch of Ablynx, VIB has spun out its fourth company with... ...investigators at VIB and Professors at Ghent University. The company has filed patent applications through VIB... ...Founded: 2020 by Flanders Institute for Biotechnology (VIB), UCB Ventures and Fund+ University collaborators: VIB-UGent, VIB...
...He was SVP and chief information officer of Teradata Corp. Belgium-based life sciences research institute VIB... ...co-managing director and head of Innovation & Business. He was head of business development of VIB’s...
...and cobas 8800 systems. VIB reveals progress with new anti-COVID-19 mechanism Flanders Institute of Biotechnology (VIB... ...the virus in early preclinical work. VIB said the group, led by Xavier Saelens at VIB... ...AG
Moderna Inc.
Sanofi
Regeneron Pharmaceuticals Inc.
Thermo Fisher Scientific Inc.
Shanghai Fosun Pharmaceutical Group Co. Ltd.
Flanders Institute for Biotechnology (VIB)
mRNA-1273
BNT162
COVID-19
cov19count
cov19count...
...to include therapies to treat COVID-19. A Belgian team led by Flanders Institute for Biotechnology (VIB... ...domain that’s conserved between SARS-CoV and SARS-CoV-2. Tim Van Acker, who is BD manager at VIB... ...Biologics Inc.
National Institutes of Health
Regeneron Pharmaceuticals Inc.
BARDA
Ghent University
WuXi Biologics Inc.
Ligand Pharmaceuticals Inc.
Flanders Institute for Biotechnology (VIB)
COVID19
coronavirus
cov19sci
cov19count
cov19count
cov19sci...
...Ventures in as many weeks. Droia, which teamed up with the Flanders Institute for Biotechnology (VIB... ...destroyed to treat solid tumors. Instead, Montis’ scientific founders Peter Carmeliet and Massimiliano Mazzone at VIB-KU... ...Clinical status: Preclinical Founded: 2019 by Droia Ventures; KU Leuven; VIB University collaborators: KU Leuven; VIB...
...Inc. New antibody against 2019-nCoV from VIB-UGent, NIH, UT Austin A collaboration between researchers at VIB-UGent... ...human receptor for viral binding. ACE2 is the cognate receptor of the SARS-CoV S protein. VIB... ...Angiotensin-converting enzyme 2 (ACE2) BTK - Bruton’s tyrosine kinase
BioCentury Staff
PRN2246, SAR442168
Flanders Institute for Biotechnology (VIB)
Ghent...
Just days after completing its IPO, Viela will receive another cash infusion from a partnership giving Mitsubishi Tanabe territorial rights to lead program inebilizumab to treat neuromyelitis optical spectrum disorder. Viela Bio Inc. (NASDAQ:VIE) will...
Autoimmune disease company Viela proposed Thursday to raise up to $150 million in an IPO -- two days after FDA accepted its first BLA for review, and two months after it closed a $75 million...
...Nearly 20 years since the launch of Ablynx, VIB has spun out its fourth company with... ...investigators at VIB and Professors at Ghent University. The company has filed patent applications through VIB... ...Founded: 2020 by Flanders Institute for Biotechnology (VIB), UCB Ventures and Fund+ University collaborators: VIB-UGent, VIB...
...He was SVP and chief information officer of Teradata Corp. Belgium-based life sciences research institute VIB... ...co-managing director and head of Innovation & Business. He was head of business development of VIB’s...
...and cobas 8800 systems. VIB reveals progress with new anti-COVID-19 mechanism Flanders Institute of Biotechnology (VIB... ...the virus in early preclinical work. VIB said the group, led by Xavier Saelens at VIB... ...AG
Moderna Inc.
Sanofi
Regeneron Pharmaceuticals Inc.
Thermo Fisher Scientific Inc.
Shanghai Fosun Pharmaceutical Group Co. Ltd.
Flanders Institute for Biotechnology (VIB)
mRNA-1273
BNT162
COVID-19
cov19count
cov19count...
...to include therapies to treat COVID-19. A Belgian team led by Flanders Institute for Biotechnology (VIB... ...domain that’s conserved between SARS-CoV and SARS-CoV-2. Tim Van Acker, who is BD manager at VIB... ...Biologics Inc.
National Institutes of Health
Regeneron Pharmaceuticals Inc.
BARDA
Ghent University
WuXi Biologics Inc.
Ligand Pharmaceuticals Inc.
Flanders Institute for Biotechnology (VIB)
COVID19
coronavirus
cov19sci
cov19count
cov19count
cov19sci...
...Ventures in as many weeks. Droia, which teamed up with the Flanders Institute for Biotechnology (VIB... ...destroyed to treat solid tumors. Instead, Montis’ scientific founders Peter Carmeliet and Massimiliano Mazzone at VIB-KU... ...Clinical status: Preclinical Founded: 2019 by Droia Ventures; KU Leuven; VIB University collaborators: KU Leuven; VIB...
...Inc. New antibody against 2019-nCoV from VIB-UGent, NIH, UT Austin A collaboration between researchers at VIB-UGent... ...human receptor for viral binding. ACE2 is the cognate receptor of the SARS-CoV S protein. VIB... ...Angiotensin-converting enzyme 2 (ACE2) BTK - Bruton’s tyrosine kinase
BioCentury Staff
PRN2246, SAR442168
Flanders Institute for Biotechnology (VIB)
Ghent...
Just days after completing its IPO, Viela will receive another cash infusion from a partnership giving Mitsubishi Tanabe territorial rights to lead program inebilizumab to treat neuromyelitis optical spectrum disorder. Viela Bio Inc. (NASDAQ:VIE) will...
Autoimmune disease company Viela proposed Thursday to raise up to $150 million in an IPO -- two days after FDA accepted its first BLA for review, and two months after it closed a $75 million...